EGFR and neoplasm: However, under conditions of growth factor-deprivation that yield cells sensitive to EGF (epidermal growth factor), IL-35 can inhibit expression of PD-L1+ in the ADC (lung adenocarcinoma) tumor cell line without impacting EGFR (epidermal growth factor receptor) (Figure 3) (39).